BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2577883)

  • 1. Management of intestinal obstruction in ovarian cancer.
    Krebs HB; Helmkamp F
    Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2577883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of intestinal obstruction in ovarian cancer.
    Krebs HB; Helmkamp BF
    Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2491443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.
    Abu-Rustum NR; Barakat RR; Venkatraman E; Spriggs D
    Gynecol Oncol; 1997 Mar; 64(3):493-5. PubMed ID: 9062158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of bowel obstruction in advanced ovarian carcinoma.
    Krebs HB; Goplerud DR
    Obstet Gynecol; 1983 Mar; 61(3):327-30. PubMed ID: 6823374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient management of small bowel obstruction in terminal ovarian cancer.
    Hopkins MP; Roberts JA; Morley GW
    J Reprod Med; 1987 Nov; 32(11):827-9. PubMed ID: 3123672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
    Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
    Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefit of palliative surgery for bowel obstruction in recurrent ovarian carcinoma].
    Li ZT; Wu XH; Fu SL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):260-3. PubMed ID: 15130355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer.
    Jong P; Sturgeon J; Jamieson CG
    Can J Surg; 1995 Oct; 38(5):454-7. PubMed ID: 7553472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intestinal occlusion in cancer].
    Medina-Franco H
    Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():100-5. PubMed ID: 16881208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents.
    Carter J; Valmadre S; Dalrymple C; Atkinson K; Young C
    Gynecol Oncol; 2002 Jan; 84(1):176-9. PubMed ID: 11748998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intestinal intubation in obstruction of the small intestine due to carcinoma of the ovary.
    Krebs HB; Goplerud DR
    Surg Gynecol Obstet; 1984 May; 158(5):467-71. PubMed ID: 6710315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of intestinal obstruction in the patient with ovarian cancer.
    Randall TC; Rubin SC
    Oncology (Williston Park); 2000 Aug; 14(8):1159-63; discussion 1167-8, 1171-5. PubMed ID: 10989827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
    Jatoi A; Podratz KC; Gill P; Hartmann LC
    J Support Oncol; 2004; 2(4):323-34; discussion 334-7. PubMed ID: 15357517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
    Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
    Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
    Chi DS; Phaƫton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
    Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of intestinal obstruction in terminal care.
    Frank C
    Can Fam Physician; 1997 Feb; 43():259-65. PubMed ID: 9040913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of intestinal obstruction in advanced ovarian cancer an analysis of 57 cases].
    Sun X; Li X; Li H
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):39-42. PubMed ID: 7656786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.